TransMedics Group, Inc. (TMDX)

NASDAQ: TMDX · Real-Time Price · USD

88.24

+19.26 (27.92%)

At close: Nov 6, 2026, 4:00 PM EST

88.00

-0.24 (-0.27%)

After-hours: Nov 6, 2026, 7:58 PM EST

TransMedics Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	727.65	605.49	441.54	241.62	93.46	30.26
Revenue Growth	28.48%	37.13%	82.74%	158.53%	208.83%	18.03%
Cost of Revenue	301.22	242.69	179.46	87.53	28.19	9.1
Gross Profit	426.43	362.81	262.08	154.09	65.27	21.16
Selling, General & Admin	233.59	185.17	168.62	119.55	69.9	38.28
Research & Development	106.39	69.06	55.97	36.06	26.81	22.3
Operating Expenses	339.98	254.22	224.59	155.61	96.71	60.59
Operating Income	86.45	108.58	37.5	-1.52	-31.44	-39.43
Interest Expense	-25.02	-13.78	-14.41	-10.79	-3.73	-3.87
Interest & Investment Income	12.4	11.4	13.4	-	-	-
Currency Exchange Gain (Loss)	-2.9	-1	0.7	-	-	-1
Other Non Operating Income (Expenses)	2.7	2.32	-1.41	12.85	-0.43	0.12
EBT Excluding Unusual Items	73.62	107.52	35.78	0.54	-35.59	-44.18
Other Unusual Items	-	-	-	-	-0.58	-
Pretax Income	73.62	107.52	35.78	-26.67	-36.17	-44.18
Income Tax Expense	-70.83	-82.77	0.32	-1.64	0.07	0.04
Net Income	144.45	190.29	35.46	-25.03	-36.23	-44.22
Net Income to Common	144.45	190.29	35.46	-25.03	-36.23	-44.22
Net Income Growth	57.42%	436.58%	-	-	-	-
Shares Outstanding (Basic)	34	34	33	33	30	28
Shares Outstanding (Diluted)	37	41	35	33	30	28
Shares Change	-4.65%	15.12%	8.30%	10.02%	7.02%	11.80%
EPS (Basic)	4.19	5.60	1.07	-0.77	-1.23	-1.60
EPS (Diluted)	3.88	4.87	1.01	-0.77	-1.23	-1.60
EPS Growth	52.80%	382.53%	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	44.7	133.59	-80.94	-164.88	-57.72	-32.38
Free Cash Flow Per Share	1.20	3.29	-2.30	-5.07	-1.95	-1.17
Gross Margin	58.60%	59.92%	59.36%	63.77%	69.84%	69.92%
Operating Margin	11.88%	17.93%	8.49%	-0.63%	-33.64%	-130.29%
Profit Margin	19.85%	31.43%	8.03%	-10.36%	-38.77%	-146.11%
Free Cash Flow Margin	6.14%	22.06%	-18.33%	-68.24%	-61.76%	-107.01%
EBITDA	123.86	134.47	57.25	6.66	-27.96	-37.61
EBITDA Margin	17.02%	22.21%	12.97%	2.76%	-29.92%	-124.28%
D&A For EBITDA	37.41	25.89	19.76	8.18	3.48	1.82
EBIT	86.45	108.58	37.5	-1.52	-31.44	-39.43
EBIT Margin	11.88%	17.93%	8.49%	-0.63%	-33.64%	-130.29%
Effective Tax Rate	-	-	0.88%	-	-	-
Revenue as Reported	727.65	605.49	441.54	241.62	93.46	30.26

SEC Filings: 10-K · 10-Q